世界の自家脂肪移植市場 – 業界動向と2031年までの予測

自己脂肪移植市場の分析と規模

自家脂肪移植市場は、低侵襲美容処置の需要増加と脂肪採取および処理技術の進歩により、着実に成長しています。美容処置における自然で長持ちする結果への嗜好の高まりが、主にこの市場を牽引しています。技術の進歩と美容処置の受容が、市場を前進させると予想されます。

世界の自家脂肪移植市場規模は、2023年に12億9,000万米ドルと評価され、2024年から2031年の予測期間中に9.8%のCAGRで成長し、2031年には27億3,000万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

レポートの範囲と市場セグメンテーション       

市場の定義        

自家脂肪移植、脂肪移植、脂肪注入は、体のある部分から別の部分に脂肪を移植する美容処置です。脂肪は通常、脂肪吸引法を使用して、太もも、腹部、臀部などの脂肪が豊富な部分から採取されます。採取された脂肪は、処理および精製されてから、顔、胸部、臀部などの体の別の部分に注入され、ボリュームと輪郭が強調されます。この処置は、加齢、外傷、または手術によりボリュームが失われた部分の外観を改善するために、形成外科手術および再建外科手術でよく使用されます。

自己脂肪移植市場の動向

ドライバー

• 技術革新

市場では、特に脂肪採取および処理技術において、大きな技術的進歩が見られます。超音波補助脂肪吸引や遠心分離システムなどの新しい技術により、脂肪移植手術の効率と結果が向上しています。これらの進歩により、手術の安全性、有効性、予測可能性が向上し、市場の成長が促進され、潜在的な用途の範囲が拡大しています。

• 美容整形以外の用途も増加

自家脂肪移植の使用は、従来の美容整形手術を超えて拡大しています。乳房切除後の乳房再建や外傷または手術後の顔面再建などの再建手術での使用が増えています。脂肪移植は汎用性と自然さを兼ね備えているため、さまざまな医療分野で貴重なツールとなり、多様な用途での採用を促進し、市場の可能性を拡大しています。

• 非侵襲的処置の需要の高まり

最小限のダウンタイムで自然な仕上がりを求める声から、自家脂肪移植を含む低侵襲性または非侵襲性の美容処置に対する需要が高まっています。患者は、より侵襲的な手術に伴うリスクや合併症を回避しながら、微妙な改善効果が得られる処置を求める傾向が高まっています。この傾向は、大手術を必要とせずに外観を改善するための安全で効果的な選択肢を提供するため、市場の成長を後押ししています。

機会

• 新興市場への進出

One significant opportunity for the market lies in expanding into emerging markets. As disposable incomes rise and awareness about aesthetic procedures increases in countries across Asia, Latin America, and Africa, there is a growing demand for cosmetic treatments, including autologous fat grafting. By targeting these regions and adapting strategies to suit local preferences and regulations, companies can tap into new markets and create new opportunities for market growth.

• Integration with Regenerative Medicine

Fat tissue contains a high concentration of stem cells, which have the potential to regenerate damaged tissues and promote healing. Integrating autologous fat grafting with regenerative medicine techniques, such as stem cell therapy, the market can offer advanced treatments for a wide range of medical conditions, including orthopedic injuries, wound healing, and tissue regeneration. This integration not only expands the market's potential applications but also positions it at the forefront of regenerative medicine, attracting interest from both patients and healthcare providers seeking innovative treatments.

Restraints/Challenges

• Standardization of Techniques and Outcomes

A key challenge for the market is the lack of standardized techniques and outcomes assessment. The procedure's success relies heavily on the skills and experience of the practitioner, leading to variability in results. This lack of standardization makes it challenging to compare outcomes between different practitioners and clinics, hindering the establishment of best practices and quality assurance measures and restrainting the market growth.

• Limited Long-Term Data

The limited long-term data available on the safety and efficacy of autologous fat grafting procedures is a challenge for the market. While short-term results are generally favorable, there is a lack of comprehensive, long-term studies assessing the outcomes and potential complications of these procedures. This lack of data can lead to uncertainty among patients and healthcare providers, impacting the adoption rate of autologous fat grafting, which is a huge challenge for the market.

This autologous fat grafting market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the autologous fat grafting market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2023, Bimini Health Tech announced the acquisition of many of Ideal Implant, Inc.'s assets, including intellectual property, regulatory approvals, product inventory, and some manufacturing capacity. This strategic move is expected to enhance the organization's revenue streams
• In April 2022, Bimini Health Tech, a globally diversified company specializing in medical aesthetics and regenerative therapy, received approval from Canada's Medical Devices Directorate to market its Dermapose family of microsizing syringe products in Canada. This approval is anticipated to contribute to the organization's revenue growth

Global Autologous Fat Grafting Market Scope

The autologous fat grafting market is categorized into six notable segments based on  product type, application, gender, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Product Type

• Liposuction Systems
• Aspiration and Harvesting Systems
• Fat Processing Systems
• Integrated Fat Transfer Systems
• De-Epithelialization Devices
• Accessories

Application

• Breast Augmentation
• Buttock Augmentation
• Facial Fat Grafting
• Hand Rejuvenation
• Others

Gender

• Female
•  Male

Age Group

• 41-50
•  20-40
•  Above 50

End User

• Hospitals
•  Plastic Surgery Centers
•  On-Site Clinics
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Autologous Fat Grafting Market Regional Analysis/Insights

The autologous fat grafting market is analyzed and market size insights and trends are provided by country, product type, application, gender, age group, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to factors such as the presence of well-established healthcare infrastructure, high adoption rates of cosmetic procedures, and strong presence of key market players in the region. The U.S., in particular, is expected to contribute significantly to the North America market share due to factors such as increasing investments in autologous fat grafting research and development and a strong presence of skilled healthcare professionals.

Asia-Pacific is expected to witness significant growth during the forecast period due to factors such as increasing disposable incomes, rising awareness about cosmetic procedures, and a growing aging population seeking aesthetic treatments. The region has large population base presents a significant market opportunity for companies operating in the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The autologous fat grafting market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for autologous fat grafting market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the autologous fat grafting market. The data is available for historic period 2016-2021.

Competitive Landscape and Autologous Fat Grafting Market Share Analysis

The autologous fat grafting market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the autologous fat grafting market are:

• AbbVie Inc. (U.S.)
• Alma Lasers (Israel)
• Tulip Aesthetics (U.S.)
• Bimini Health Tech (U.S.)
• Aspire Medical Innovation (U.S.)
• Sterimedix Limited (U.K.)
• Genesis Biosystems (U.S.)
• MTF Biologics (U.S.)
• MicroAire (U.S.)
• Medicon eG (Germany)
• Human Med AG (Germany)
• Lipogems International S.p.A. (Italy)
• HK Surgical Inc. (U.S.)
• MÖLLER Medical GmbH (Germany)
• Grey Medical (U.S.)Top of Form

SKU-58670